avb3 integrin antagonists (University of Barcelona/Fundació BOSCH I GIMPERA)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameavb3 integrin antagonists (University of Barcelona/Fundació BOSCH I GIMPERA)
Drug Alias Namealpha-v/beta-3 integrin antagonists (University of Barcelona/Fundació BOSCH I GIMPERA)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversitat De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversitat De Barcelona
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A